Year 2021 / Volume 28 / Number 6

Review

Recommendations for the safe prescription of opioids in patients with a history or risk of abuse

Rev. Soc. Esp. Dolor. 2021; 28(6): 343-349 / DOI: 10.20986/resed.2022.3935/2021

Omar Fernando Gomezese, Daniela Seija, Sonia Margarita Vivas, Andrea Juliana Gutiérrez


ABSTRACT

Chronic pain is one of the most frequent medical problems and its relief should be a priority therapeutic goal; Opioid analgesics constitute the cornerstone, however, in chronic pain and the addictive potential of these drugs, as well as their misuse and the worrying increase in overdose deaths in some countries such as the US, have forced health authorities to implement coordinated strategies to promote safe and responsible prescribing, to mitigate risks in the use of opioids.



RESUMEN

El dolor crónico es uno de los problemas médicos más frecuentes y su alivio debe ser una meta terapéutica prioritaria. Los analgésicos opioides constituyen la piedra angular. Sin embargo, en dolor crónico y el potencial adictivo de estos fármacos, así como su uso indebido y el preocupante aumento de muertes por sobredosis en algunos países como EE. UU., han obligado a las autoridades de salud a implementar estrategias coordinadas para promover la prescripción segura y responsable para mitigar los riesgos en el uso de opioides.





Complete Article

Nuevo comentario

Security code:
CAPTCHA code image
Speak the codeChange the code
 

Comentarios

No comments in this article

Bibliografía

1. Verástegui E, Plancarte R, Domínguez J, Burgos R, Arrieta O, Campillo C, et al. Recomendaciones para la prescripción segura de opioides en el manejo del dolor crónico no oncológico. Gac Med Mex. 2018;154(4):532-3.
2. Tutt B. Administración del uso de opioides en pacientes con cáncer. OncoLog. 2018;63(3).
3. González Gragera MB. Santamaría Semís J, Rodríguez Quintana R, Iglesias González M, Julià i Torras J. Adicción frente a seudoadicción. Med Paliat. 2015;22(S1):20-6.
4. Paice J. Risk Assessment and monitoring of patients with cancer receiving opioid therapy . Oncologist. 2019;24(10):1294-8.
5. O'Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, Mcquay HJ, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain. 2017;21(1):3-19.
6. Opioids Aware [Internet]. Faculty of Pain Medicine of the Royal College of Anaesthetists; 2022. Disponible en: https://fpm.ac.uk/opioids-aware
7. Sobredosis de opioides [Internet]. Organizacion Mundial de la Salud; 2020. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/opioid-overdose
8. World Drug Report 2019 [Internet]. United Nations; 2022. Disponible en: https://wdr.unodc.org/wdr2019/
9. Opioid Overdose Crisis [Internet]. National Institutes of Health; 2021. Disponible en: https://www.drugabuse.gov/drug-topics/opioids/opioid-overdose-crisis
10. Glosario y términos de alcohol y drogas [Internet]. World Health Organization; 1994. Disponible en: https://www.who.int/substance_abuse/terminology/lexicon_alcohol_drugs_spanish.pdf
11. Carmona-Bayonas A, Jiménez-Fonseca P, Castañón E, Ramchandani-Vaswani A, Sánchez-Bayona R, Custodio A, et al. Chronic opioid therapy in long term cancer survivors. Clin Transl Oncol. 2017;19(2):236-50. DOI: 10.1007/s12094-016-1529-6.
12. Guía de consulta de los Criterios Diagnósticos del DSM-5 [Internet]. American Psychiatric Association; 2014. Disponible en: https://www.eafit.edu.co/ninos/reddelaspreguntas/Documents/dsm-v-guia-consulta-manual-diagnostico-estadistico-trastornos-mentales.pdf
13. George B, Minello C, Allano G, Maindet C, Burnod A, Lemaire A. Opioids in cancer-related pain: current situation and outlook. Support Care Cancer. 2019;27(8):3105-18.
14. Boscarino J, Rukstalis M, Hoffman S, Han JJ, Erlich PM, Gerhard GS, et sl. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction. 2010;105(10):1776-82.
15. Fabbro E. Assessment and Management of Chemical Coping in Patients With Cancer. J Clin Oncol. 2014;32(16):1734-8.
16. Salsitz E. Chronic Pain, Chronic Opioid Addiction: a Complex Nexus. J Med Toxicol. 2016;12(1):54-7.
17. Pineda-Ortiz J, Torrecilla-Sesma M. Mecanismos neurobiológicos de la adicción a drogas. Trastornos Adictivos. 1999;1(1):13-21.
18. Acuña JP. Riesgo de adicción a analgésicos opioides en el tratamiento de dolor crónico no oncológico. Revista Médica Clínica Las Condes. 2019;30(6):466-79.
19. Nestler E. Under siege: The brain on opiates. Neuron. 1996;16(5):897-900.
20. Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22(2):173-81.
21. Kosten T, George T. The Neurobiology of Opioid Dependence: Implications for Treatment. Sci Pract Perspect. 2002;1(1):13-20.
22. Sehgal N, Manchikanti L, Smith HS. Prescription Opioid Abuse in Chronic Pain: A Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse. Pain Physician. 2012;15(3 Suppl):ES67-92.
23. Brown RL, Leonard T, Saunders LA, Papasouliotis O. The prevalence and detection of substance use disorder among inpatients ages 18 to 49: an opportunity for prevention. Preventive Medicine. 1998;27(1):101-10.
24. Carvajal Valcárcel A, Martínez García M, Centeno Cortés C. Versión española del Edmonton Symptom Assessment Sytem (ESAS): un instrumento de referencia para la valoración sintomática del paciente con cáncer avanzado. Med Paliat. 2013;20(4):143-9.
25. Pain Management Best Practices [Internet]. Inter-Agency Task Force, U.S. Department of Health and Human Services; 2019. Disponible en: https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf
26. Becker WC, Edelman EJ, Starrels JL, Azari S, Roy P, Young SR, et al. Consensus-Based Treatment Approaches for Managing Concerning Behaviors in Patients on Long-term Opioid Therapy for Chronic Pain: Case-Based Applications. Mayo Clin Proc Innov Qual Outcomes. 2018;2(2):91-8.
27. Parisi A, Pensieri MV, Cortellini A, D'Orazio C, Ficorella C, Verna L, et al. Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series. J Addict Dis. 2020;38(2):229-34.
28. Ramírez Arias E. Diagnóstico y tratamiento de la dependencia a los opioides. Rev Med Costa Rica y Centroam. 2013;LXX(608):593-7.

Artículos relacionados

Pharmacogenetics in analgesic response: towards a sex-differences personalized medicine

Rev. Soc. Esp. Dolor. 2023; 30(2): 115-124 / DOI: 10.20986/resed.2023.4042/2022

Review of the remission and management of a cancer related pain population to a pain unit. What can we improve?

Rev. Soc. Esp. Dolor. 2023; 30(1): 7-14 / DOI: 10.20986/resed.2023.4010/2022

How to prevent the abuse of opioids without hindering access to them for those patients who need them?

Rev. Soc. Esp. Dolor. 2023; 30(1): 1-2 / DOI: 10.20986/resed.2023.4078/2023

The biopsychosocial nature of chronic pelvic floor pain: a narrative review

Rev. Soc. Esp. Dolor. 2022; 29(2): 97-113 / DOI: 10.20986/resed.2022.3981/2022

Attitudes and current knowledge of the spanish pain treatment specialist regarding medical cannabis

Rev. Soc. Esp. Dolor. 2022; 29(13): 52-57 / DOI: 10.20986/resed.2022.4032/2022

Cannabinoids in neuropathic pain: lights and shadows

Rev. Soc. Esp. Dolor. 2022; 29(13): 20-26 / DOI: 10.20986/resed.2022.4027/2022

Bone pain management with opioid medication in a patient with Camurati-Engelmann disease: a case report

Rev. Soc. Esp. Dolor. 2022; 29(1): 51-55 / DOI: 10.20986/resed.2021.3930/2021

OFA in major surgery. Experience at a secondary level hospital

Rev. Soc. Esp. Dolor. 2022; 29(1): 8-14 / DOI: 10.20986/resed.2022.3991/2022

New opioids with different intracellular mechanism of action; is a new therapeutic window opening up?

Rev. Soc. Esp. Dolor. 2021; 28(5): 292-297 / DOI: 10.20986/resed.2021.3891/2021

Efficacy and complications of analgesic techniques for the treatment of moderate to severe postoperative acute pain

Rev. Soc. Esp. Dolor. 2021; 28(5): 264-265 / DOI: 10.20986/resed.2021.3942/2021

Postoperative ketamine efficacy in patients receiving chronic opioids undergoing spinal surgery

Rev. Soc. Esp. Dolor. 2021; 28(2): 92-99 / DOI: 10.20986/resed.2021.3825/2020

Evolution of low back pain in cancer patients treated with interventional pain management

Rev. Soc. Esp. Dolor. 2021; 28(2): 76-81 / DOI: 10.20986/resed.2021.3901/2021

Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome

Rev. Soc. Esp. Dolor. 2021; 28(2): 71-75 / DOI: 10.20986/resed.2021.3822/2020

Parsonage-turner after rabies vaccination due to bat bite: case report

Rev. Soc. Esp. Dolor. 2021; 28(1): 57-61 / DOI: 10.20986/resed.2021.3832/2020

Management and perception of therapeutic adherence of breakthrough cancer pain by oncologists in Spain

Rev. Soc. Esp. Dolor. 2021; 28(1): 19-26 / DOI: 10.20986/resed.2021.3824/2020

Opioids in osteoarthritis

Rev. Soc. Esp. Dolor. 2021; 28(13): 49-56 / DOI: 10.20986/resed.2021.3855/2020

Transitional pain clinic

Rev. Soc. Esp. Dolor. 2020; 27(6): 369-374 / DOI: 10.20986/resed.2020.3840/2020

School of non-oncologic chronic pain patients and opioid treatment

Rev. Soc. Esp. Dolor. 2020; 27(5): 324-328 / DOI: 10.20986/resed.2020.3804/2020

Opioid misuse in patients with cancer pain: an integrative systematic review of the literature

Rev. Soc. Esp. Dolor. 2020; 27(5): 306-315 / DOI: 10.20986/resed.2020.3801/2020

Splanchnic nerve block for the treatment of benign chronic abdominal pain. a case report and literature review

Rev. Soc. Esp. Dolor. 2020; 27(4): 273-277 / DOI: 10.20986/resed.2020.3818/2020

Clinical pathophysiology in patients with sickle cell disease: the transition from acute to chronic pain

Rev. Soc. Esp. Dolor. 2020; 27(4): 257-268 / DOI: 10.20986/resed.2020.3814/2020

Drug consumption used for musculoskeletal pain treatment in a cohort of blue-collar workers in Zaragoza (Spain)

Rev. Soc. Esp. Dolor. 2020; 27(3): 150-159 / DOI: 10.20986/resed.2020.3749/2019

Management of breakthrough pain associated with the cure of skin ulcers

Rev. Soc. Esp. Dolor. 2020; 27(2): 113-126 / DOI: 10.20986/resed.2020.3755/2019

Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review

Rev. Soc. Esp. Dolor. 2020; 27(1): 37-49 / DOI: 10.20986/resed.2020.3717/2018

Effectiveness of patient-controlled analgesia in acute and chronic pain after cardiac surgery: a prospective study

Rev. Soc. Esp. Dolor. 2020; 27(1): 24-36 / DOI: 10.20986/resed.2020.3747/2019

Key factors governing spinal cord opioid bioavailability in the management of acute pain

Rev. Soc. Esp. Dolor. 2019; 26(6): 359-367 / DOI: 10.20986/resed.2019.3737/2019

Dexmedetomidine as peripheral nerve block adjuvant

Rev. Soc. Esp. Dolor. 2019; 26(2): 103-115 / DOI: 10.20986/resed.2018.3695/2018

Fast opioid detoxification

Rev. Soc. Esp. Dolor. 2019; 26(2): 95-102 / DOI: 10.20986/resed.2019.3681/2018

Opioids and addiction in chronic pain: is it a problem?, how to address it?

Rev. Soc. Esp. Dolor. 2019; 26(2): 65-67 / DOI: 10.20986/resed.2019.3736/2019

Do our patients need opioids and benzodiazepines concurrently?

Rev. Soc. Esp. Dolor. 2019; 26(1): 59-60 / DOI: 10.20986/resed.2017.3552/2016

Project adapta: adequacy of treatment in breakthrough cancer pain

Rev. Soc. Esp. Dolor. 2019; 26(1): 31-43 / DOI: 10.20986/resed.2018.3661/2018

The use of opioids in older adults

Rev. Soc. Esp. Dolor. 2019; 26(1): 4-5 / DOI: 10.20986/resed.2019.3731/2019

Opinaudit study: clinical uses in breakthrough pain, is scientific evidence being followed up?

Rev. Soc. Esp. Dolor. 2018; 25(6): 325-334 / DOI: 10.20986/resed.2018.3634/2017

Use of major opioids for control of pain in hospitalized patients

Rev. Soc. Esp. Dolor. 2018; 25(6): 318-324 / DOI: 10.20986/resed.2018.3629/2017

Farmacologic adyuvants with saving effect of opioids in the perioperative period

Rev. Soc. Esp. Dolor. 2018; 25(5): 278-290 / DOI: 10.20986/resed.2018.3663/2018

Expenditure, prescription and consumption of analgesic drugs before and during the economic crisis

Rev Soc Esp Dolor 2018; 25(3): 155-162 / DOI: 10.20986/resed.2017.3609/2017

Control of symptoms in terminally ill patients: effectiveness of opioid treatment for breakthrough dyspnea

Rev Soc Esp Dolor 2017; 24(4): 161-168 / DOI: 10.20986/resed.2017.3582/2017

Prevalence of breakthrough pain associated with chronic low back pain in Andalusia (COLUMBUS study)

Rev Soc Esp Dolor 2017; 24(3):116-124 / DOI: 10.20986/resed.2017.3548/2016

Instrucciones para citar

Gomezese O, Seija D, Vivas S, Gutiérrez A. Recommendations for the safe prescription of opioids in patients with a history or risk of abuse. Rev Soc Esp Dolor 2021; 28(6): 343-349 / DOI: 1020986/resed20223935/2021


Descargar a un gestores de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica

Este artículo ha sido visitado 14373 veces.
Este artículo ha sido descargado 2 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 08/07/2021

Aceptado: 21/02/2022

Prepublicado: 01/03/2022

Publicado: 18/04/2022

Tiempo de revisión del artículo: 217 días

Tiempo de prepublicación: 236 días

Tiempo de edición del artículo: 284 días


Compartir

Este artículo aun no tiene valoraciones.
Reader rating:
Rate this article:
© 2024 Revista de la Sociedad Española del Dolor
ISSN: 1134-8046   e-ISSN: 2254-6189

      Indexada en: